Approximately 10% of those surveyed in a recent Gallup poll on healthcare say that government involvement is a problem, up from only 5% at the beginning of this year.
Continue reading Top Health-Care Problems: …
Here’s a roundup of some of Wednesday’s major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck’s experimental heart drug appears to work well without side…
Swiss pharmaceutical giant Roche (RHHBY) said Wednesday it is slashing 6% of its workforce, or 4,800 jobs, most of them in the U.S. This is part of the drugmaker’s plan to get a handle on costs, which comes in response to recent drug setbacks and as th…
The first stroke patient ever to be treated with stem cell therapy has reportedly been discharged from the hospital and is doing well. Stem-cell technology is viewed as a highly promising new area of medical science, but it is …
As the Anglo-Swedish drugmaker looks to divest assets, it seeks a buyer for its dental implants and medical devices unit Astra Tech.
Continue reading AstraZeneca Looking to Sell Unit for $2 Billion
…